Stockreport

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024

Purple Biotech Ltd. - American Depositary Shares  (PPBT) 
PDF NT219 found to suppress cancer stem cells that promote drug resistance to KRASG12C and KRASG12D inhibitors and solid tumor recurrence Potential biomarkers for treatme [Read more]